ResMed Inc. Sales-type Lease, Lease Income
ResMed Inc. (RMD) reported Sales-type Lease, Lease Income of $9.34 million for the 12-month period ending 2022-06-30, per its 10-K filed 2022-08-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesTypeLeaseLeaseIncome · last filed 2022-08-12
- ResMed Inc. sales-type lease, lease income for the quarter ending 2022-06-30 was $2.74M, a 29.71% decline year-over-year.
- ResMed Inc. sales-type lease, lease income for the quarter ending 2022-03-31 was $946.00K, a 53.42% decline year-over-year.
- ResMed Inc. sales-type lease, lease income for the quarter ending 2021-12-31 was $1.56M, a 16.00% decline year-over-year.
- ResMed Inc. sales-type lease, lease income for the quarter ending 2021-09-30 was $4.09M, a 108.52% increase year-over-year.
- ResMed Inc. sales-type lease, lease income for fiscal 2022 was $9.34M, a 4.26% decline from fiscal 2021.
- ResMed Inc. sales-type lease, lease income for fiscal 2021 was $9.76M, a 27.49% decline from fiscal 2020.
- ResMed Inc. sales-type lease, lease income for fiscal 2020 was $13.46M.
| Period end | Sales-type Lease, Lease Income 3 month | Sales-type Lease, Lease Income 6 month | Sales-type Lease, Lease Income 9 month | Sales-type Lease, Lease Income 12 month |
|---|---|---|---|---|
| 2022-06-30 | $2.74M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-12 | $3.69M derived: sum of 2 quarters · filed 2022-08-12 | $5.25M derived: sum of 3 quarters · filed 2022-08-12 | $9.34M 10-K · filed 2022-08-12 |
| 2022-03-31 | $946.00K 10-Q · filed 2022-04-29 | $2.51M derived: sum of 2 quarters · filed 2022-04-29 | $6.60M 10-Q · filed 2022-04-29 | $10.50M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-12-31 | $1.56M 10-Q · filed 2022-01-28 | $5.65M 10-Q · filed 2022-01-28 | $9.56M derived: sum of 3 quarters · filed 2022-08-12 | $11.59M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-09-30 | $4.09M 10-Q · filed 2021-10-29 | $7.99M derived: sum of 2 quarters · filed 2022-08-12 | $10.02M derived: sum of 3 quarters · filed 2022-08-12 | $11.88M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-06-30 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-12 | $5.93M derived: sum of 2 quarters · filed 2022-08-12 | $7.80M derived: sum of 3 quarters · filed 2022-08-12 | $9.76M 10-K · filed 2022-08-12 |
| 2021-03-31 | $2.03M 10-Q · filed 2022-04-29 | $3.89M derived: sum of 2 quarters · filed 2022-04-29 | $5.85M 10-Q · filed 2022-04-29 | $10.20M derived: sum of 4 quarters · filed 2022-08-12 |
| 2020-12-31 | $1.86M 10-Q · filed 2022-01-28 | $3.82M 10-Q · filed 2022-01-28 | $8.17M derived: sum of 3 quarters · filed 2022-08-12 | $11.95M derived: sum of 4 quarters · filed 2022-08-12 |
| 2020-09-30 | $1.96M 10-Q · filed 2021-10-29 | $6.31M derived: sum of 2 quarters · filed 2022-08-12 | $10.09M derived: sum of 3 quarters · filed 2022-08-12 | $13.16M derived: sum of 4 quarters · filed 2022-08-12 |
| 2020-06-30 | $4.35M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-12 | $8.13M derived: sum of 2 quarters · filed 2022-08-12 | $11.20M derived: sum of 3 quarters · filed 2022-08-12 | $13.46M 10-K · filed 2022-08-12 |
| 2020-03-31 | $3.78M 10-Q · filed 2021-04-30 | $6.85M derived: sum of 2 quarters · filed 2021-04-30 | $9.11M 10-Q · filed 2021-04-30 | |
| 2019-12-31 | $3.07M 10-Q · filed 2021-01-29 | $5.33M 10-Q · filed 2021-01-29 | ||
| 2019-09-30 | $2.26M 10-Q · filed 2020-10-30 |